about
Lentiviral vectors in gene therapy: their current status and future potentialGene therapy in clinical medicineMulti-OMICs and Genome Editing Perspectives on Liver Cancer Signaling NetworksGenome-editing Technologies for Gene and Cell TherapyCell Penetrating Peptide Conjugated Chitosan for Enhanced Delivery of Nucleic AcidA Current View of Functional Biomaterials for Wound Care, Molecular and Cellular TherapiesCloning humans? Biological, ethical, and social considerationsSui generis: gene therapy and delivery systems for the treatment of glioblastomaMolecular mechanism underlying lymphatic metastasis in pancreatic cancerDawn of ocular gene therapy: implications for molecular diagnosis in retinal diseaseOn methodological standards in training and transfer experiments.Gene therapy of genetic diseases and cancer.RNAi-based gene therapy for dominant Limb Girdle Muscular Dystrophies.Next generation delivery system for proteins and genes of therapeutic purpose: why and how?Intracellular trafficking of cationic liposome-DNA complexes in living cells.Gene therapy finds its niche.Efficient in vitro gene delivery by hybrid biopolymer/virus nanobiovectorsToward synthetic biology with engineered T cells: a long journey just begun.Gene therapy: here to stay.Gene therapy in glaucoma-3: Therapeutic approaches.Gene therapy in status epilepticus.Progress and prospects of gene therapy clinical trials for the muscular dystrophies.A method to facilitate and monitor expression of exogenous genes in the rat kidney using plasmid and viral vectors.Implications of the innate immune response to adenovirus and adenoviral vectors.Zinc-finger nucleases for somatic gene therapy: the next frontier.Human hyperargininemia: a mutation not expressed in skin fibroblasts?Gene therapy of monogenic and cardiovascular disorders.Approaches to gene therapy of complex multigenic diseases: cancer as a model and implications for cardiovascular disease and diabetes.Translational paradigms in cerebrovascular gene transfer.DNA Polymerases as targets for gene therapy of hepatocellular carcinoma.Identification of possible cytotoxicity mechanism of polyethylenimine by proteomics analysis.Cell-specific expression of artificial microRNAs targeting essential genes exhibit potent antitumor effect on hepatocellular carcinoma cells.Comparison of silk-elastinlike protein polymer hydrogel and poloxamer in matrix-mediated gene delivery.Long-term production and delivery of human growth hormone in vivoRetroviral vectors: new applications for an old tool.Virus-inspired approach to nonviral gene delivery vehicles.Progress in gene therapy for prostate cancerInteractions of polyoma and mouse DNA's. II. Polyoma-induced mouse DNA replication and pseudovirion formation.Viral vector-based gene transfer for treatment of chronic pain.Intergenotic transformation of the Bacillus subtilis genospecies
P2860
Q24629462-B04307DB-2CEC-426E-A923-A39B6461B540Q24680275-E80A57C5-B64C-42FE-9E18-9CA48B576590Q26741086-954F82B6-4D8D-41A1-9E8A-224530E78234Q26769662-1ABB68F4-A69F-4F6F-B782-B17924BBE8BEQ26774462-380BE46C-A59A-4577-8492-3762429935BAQ26778235-9E267385-E9C5-4ECE-9A85-736B9F13AB78Q26801506-C13BCBC2-5D3D-4AB1-9AE5-9C5CE395CCDAQ26850467-5078E860-C5C7-40B6-B583-9733C730A958Q26999345-303033ED-236E-43AC-8C91-329676A6E2D7Q27022731-8AA613F4-50C8-4CD7-8631-8F7D604082DDQ30560265-CB3D9926-4F61-4FB1-BA39-72D6A601B134Q33788236-FC49ACFB-D78B-4B4C-8D31-6BF98496D78CQ33996884-024CFBC9-A009-4390-893B-F22C0162A6E0Q34003800-8860513E-1A33-4596-B1F0-88C629682343Q34068818-4A193AEA-8473-46D7-B30C-0C089ACFC2E4Q34163207-3C7FCD3F-5FD8-4DE9-B3CD-493479FF357FQ34216718-1DFB2253-BC39-43F6-B4C8-083E81482FE4Q34240817-8207BA7A-646C-4C08-AD26-6B67A6E27604Q34279082-06857791-07B5-4A1B-9246-052B4C1599D4Q34351545-2624F156-D9BA-4F47-84DE-95E444CDEE83Q34368315-060A6E5A-5FC7-4802-B217-5AEBAD139EB7Q34497471-8726E51B-2D99-4F3C-A993-34F20B90EA4EQ34610689-C057308E-3C10-48C7-BD61-2425B8EBE938Q35085363-C4AF590F-A242-4C5C-AD83-C0BE47721BB3Q35174917-4C9FFA4B-F837-452B-A2C5-A329ED4D807CQ35202348-B2943DB7-DB9F-4717-93EF-65B6B0C4AD72Q35207521-937AA730-8BE4-4F35-BFE1-B5AEF8045304Q35454954-E800A3B1-D76A-4249-ABFB-5BBF0BBA880AQ35576698-7513B2DC-8019-44DB-A358-624673F5287BQ35579189-69FD1299-933A-4A96-974A-EE74E9B1B362Q35680941-7AC415D1-F6B2-4EE3-AFAB-25389671B18FQ35742393-BF711F75-BA99-4C52-8E48-A57B28D25BD3Q35834695-D1DCAC84-2A00-4713-9892-9F69FCF6761DQ35888390-F5780FDC-EA09-43E2-93FD-15549B1A9211Q35904404-DD05C0B9-1F3F-46B7-A216-CEDDB634E52BQ36239695-4FBF6AB0-AC84-4475-B50F-01BDDD3E6BCBQ36406911-50BE4121-3DF5-4DBB-A954-36C1FA2F4A00Q36556412-E946C0B0-0F5A-45F8-BBA0-C175F574FA4CQ36787828-373F967E-D64F-49B3-802A-9D800CB79925Q36833554-C5974231-ADFC-47FB-9B43-E00BD07F7980
P2860
description
1972 nî lūn-bûn
@nan
1972 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1972 թվականի մարտին հրատարակված գիտական հոդված
@hy
1972年の論文
@ja
1972年論文
@yue
1972年論文
@zh-hant
1972年論文
@zh-hk
1972年論文
@zh-mo
1972年論文
@zh-tw
1972年论文
@wuu
name
Gene therapy for human genetic disease?
@ast
Gene therapy for human genetic disease?
@en
Gene therapy for human genetic disease?
@nl
type
label
Gene therapy for human genetic disease?
@ast
Gene therapy for human genetic disease?
@en
Gene therapy for human genetic disease?
@nl
prefLabel
Gene therapy for human genetic disease?
@ast
Gene therapy for human genetic disease?
@en
Gene therapy for human genetic disease?
@nl
P1433
P1476
Gene therapy for human genetic disease?
@en
P2093
P304
P356
10.1126/SCIENCE.175.4025.949
P407
P577
1972-03-01T00:00:00Z